1George JN, Woolt SH, Raskob GE, et al.Idiopathic thro-mbocytopenic purpura: a practice guideline developed by explicit method for the American Society of Hematology.Blood, 1996, 88(1): 3-40.
2Kuhne T, Imbach P, Bolton-maggs PH, et al.Newly diagnosed idiopathic thrombocytopenic purpura in chil-dhood: an observation study.Lancet, 2001, 358(9299): 2122-2125.
3Blanchette V, Carcao M.Approach to the investigation and management of immune thrombocytopenic purpura in children.Semin Hematol, 2000, 37(3): 299-314.
4Blanchette V, Freedman J, Garvey B.Management of chronic immune thrombocytopenic purpura in children and adult.Semin Hematol, 1998, 35(suppl): 36-51.
8Dickerhoff R, Von Ruecher A.The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobins or sustained prednisone treatment.J Pediatr, 2000, 137(5): 629-632.
9George JN.Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient?J Pediatr, 2000, 137(5): 598-600.
10Portielje JE, Westerdorp RGJ, Kluin-Nelemans HC, et al.Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.Blood, 2001, 97(9): 2549-2554.
